WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2010115238) METHOD FOR TREATING IMMUNE DISORDERS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2010/115238    International Application No.:    PCT/AU2010/000394
Publication Date: 14.10.2010 International Filing Date: 07.04.2010
IPC:
A61K 39/395 (2006.01), A61P 37/00 (2006.01)
Applicants: IMMUNE SYSTEM THERAPEUTICS LTD [AU/AU]; Level 8 235 Jones Street Ultimo, New South Wales 2007 (AU) (For All Designated States Except US).
HUTCHINSON, Andrew, Tasman [AU/AU]; (AU) (For US Only).
JONES, Darren, Ross [AU/AU]; (AU) (For US Only).
RAISON, Robert, Lindsay [AU/AU]; (AU) (For US Only).
ASVADI, Parisa [AU/AU]; (AU) (For US Only).
DUNN, Rosanne [AU/AU]; (AU) (For US Only)
Inventors: HUTCHINSON, Andrew, Tasman; (AU).
JONES, Darren, Ross; (AU).
RAISON, Robert, Lindsay; (AU).
ASVADI, Parisa; (AU).
DUNN, Rosanne; (AU)
Agent: FB RICE & CO; Level 23 200 Queen Street Melbourne, Victoria 3000 (AU)
Priority Data:
61/167,497 07.04.2009 US
Title (EN) METHOD FOR TREATING IMMUNE DISORDERS
(FR) MÉTHODE DE TRAITEMENT DE TROUBLES IMMUNITAIRES
Abstract: front page image
(EN)The present invention relates to the treatment of B-cell mediated immune disorders such as rheumatoid arthritis, systemic lupus erythromatomus, diabetes mellitus, and multiple sclerosis. In particular, the present invention relates to the treatment of B-cell mediated immune disorders using antibodies which bind to membrane-bound free light chain expressed on the surface of plasma cell precursors.
(FR)La présente invention concerne le traitement de troubles immunitaires médiés par les lymphocytes B, tels que l'arthrite rhumatoïde, le lupus érythémateux systémique, le diabète sucré, et la sclérose multiple. En particulier, la présente invention concerne le traitement de troubles immunitaires médiés par les lymphocytes B au moyen d'anticorps qui se lient à une chaîne légère libre liée à une membrane, exprimée à la surface de précurseurs de plasmocytes.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)